{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:54:15Z","timestamp":1780566855462,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2014-6788"],"award-info":[{"award-number":["2014-6788"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10549-019-05410-w","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T12:02:42Z","timestamp":1566820962000},"page":"573-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms"],"prefix":"10.1007","volume":"178","author":[{"given":"Joost G. E.","family":"Verbeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Atema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne C.","family":"Mewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester S. A.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"van Beurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra S.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim H.","family":"van Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5624-3234","authenticated-orcid":false,"given":"Valesca P.","family":"Ret\u00e8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"issue":"5","key":"5410_CR1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718\u20131729","journal-title":"J Clin Oncol"},{"issue":"26","key":"5410_CR2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","volume":"344","author":"CL Shapiro","year":"2001","unstructured":"Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344(26):1997\u20132008","journal-title":"N Engl J Med"},{"issue":"8","key":"5410_CR3","first-page":"1311","volume":"26","author":"JS Carpenter","year":"1999","unstructured":"Carpenter JS, Andrykowski MA (1999) Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 26(8):1311\u20131317","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"5410_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13697130500487224","volume":"9","author":"P Gupta","year":"2006","unstructured":"Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I (2006) Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9(1):49\u201358","journal-title":"Climacteric"},{"issue":"3","key":"5410_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/0167482X.2016.1216963","volume":"38","author":"Z Moon","year":"2016","unstructured":"Moon Z, Hunter MS, Moss-Morris R, Hughes LD (2016) Factors related to the experience of menopausal symptoms in women prescribed tamoxifen. J Psychosom Obstet Gynaecol 38(3):226\u2013235","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"2","key":"5410_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","volume":"134","author":"CC Murphy","year":"2012","unstructured":"Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134(2):459\u2013478","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5410_CR7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.22485","volume":"109","author":"TI Barron","year":"2007","unstructured":"Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109(5):832\u2013839","journal-title":"Cancer"},{"issue":"4","key":"5410_CR8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.hoc.2013.05.005","volume":"27","author":"D Stan","year":"2013","unstructured":"Stan D, Loprinzi CL, Ruddy KJ (2013) Breast cancer survivorship issues. Hematol\/Oncol Clin 27(4):805\u2013827","journal-title":"Hematol\/Oncol Clin"},{"issue":"17","key":"5410_CR9","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","volume":"295","author":"HD Nelson","year":"2006","unstructured":"Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295(17):2057\u20132071","journal-title":"JAMA"},{"issue":"9488","key":"5410_CR10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","volume":"366","author":"KJ Pandya","year":"2005","unstructured":"Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366(9488):818\u2013824","journal-title":"Lancet"},{"issue":"29","key":"5410_CR11","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","volume":"29","author":"AH Boekhout","year":"2011","unstructured":"Boekhout AH, Vincent AD, Dalesio OB, van den Bosch J, Foekema-Tons JH, Adriaansz S, Sprangers S, Nuijen B, Beijnen JH, Schellens JH (2011) Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29(29):3862\u20133868","journal-title":"J Clin Oncol"},{"issue":"11","key":"5410_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pon.793","volume":"13","author":"MS Hunter","year":"2004","unstructured":"Hunter MS, Grunfeld EA, Mittal S, Sikka P, Ramirez AJ, Fentiman I, Hamed H (2004) Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 13(11):769\u2013778","journal-title":"Psychooncology"},{"key":"5410_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.2044-8287.1996.tb00496.x","volume":"1","author":"MS Hunter","year":"1996","unstructured":"Hunter MS, Liao KLM (1996) Evaluation of a four-session cognitive-behavioural intervention for menopausal hot flushes. Br J Health Psychol 1:113\u2013125","journal-title":"Br J Health Psychol"},{"issue":"3","key":"5410_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(11)70364-3","volume":"13","author":"E Mann","year":"2012","unstructured":"Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, Hunter MS (2012) Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol 13(3):309\u2013318","journal-title":"Lancet Oncol"},{"issue":"7","key":"5410_CR15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/gme.0b013e31823fe835","volume":"19","author":"B Ayers","year":"2012","unstructured":"Ayers B, Smith M, Hellier J, Mann E, Hunter MS (2012) Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 19(7):749\u2013759","journal-title":"Menopause"},{"issue":"33","key":"5410_CR16","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2012.41.8525","volume":"30","author":"SFA Duijts","year":"2012","unstructured":"Duijts SFA, Van Beurden M, Oldenburg HSA, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MBE, Plaisir PW, Rijna H et al (2012) Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized controlled multicenter trial. J Clin Oncol 30(33):4124\u20134133","journal-title":"J Clin Oncol"},{"issue":"7","key":"5410_CR17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/GME.0000000000000836","volume":"24","author":"V Atema","year":"2017","unstructured":"Atema V, van Leeuwen M, Oldenburg HSA, van Beurden M, Hunter MS, Aaronson NK (2017) An Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: results of a pilot study. Menopause 24(7):762\u2013767","journal-title":"Menopause"},{"issue":"1","key":"5410_CR18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1186\/s12885-016-2946-1","volume":"16","author":"V Atema","year":"2016","unstructured":"Atema V, van Leeuwen M, Oldenburg HS, Retel V, van Beurden M, Hunter MS, Aaronson NK (2016) Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors. BMC Cancer 16(1):920","journal-title":"BMC Cancer"},{"issue":"10","key":"5410_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1200\/JCO.18.00655","volume":"37","author":"V Atema","year":"2019","unstructured":"Atema V, van Leeuwen M, Kieffer JM, Oldenburg HSA, van Beurden M, Gerritsma MA, Kuenen MA, Plaisier PW, Lopes Cardozo AMF, van Riet YEA et al (2019) Efficacy of internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Clin Oncol 37(10):809\u2013822","journal-title":"J Clin Oncol"},{"issue":"5","key":"5410_CR20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00019053-200017050-00004","volume":"17","author":"A Brennan","year":"2000","unstructured":"Brennan A, Akehurst R (2000) Modelling in health economic evaluation. What is its place? What is its value? PharmacoEconomics 17(5):445\u2013459","journal-title":"PharmacoEconomics"},{"issue":"1","key":"5410_CR21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11764-014-0396-9","volume":"9","author":"JC Mewes","year":"2015","unstructured":"Mewes JC, Steuten LM, Duijts SF, Oldenburg HS, van Beurden M, Stuiver MM, Hunter MS, Kieffer JM, van Harten WH, Aaronson NK (2015) Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv 9(1):126\u2013135","journal-title":"J Cancer Surviv"},{"issue":"1","key":"5410_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios JM, Shau WY (2014) Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 17(1):5\u201314","journal-title":"Value Health"},{"issue":"6","key":"5410_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"11","key":"5410_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","volume":"51","author":"NK Aaronson","year":"1998","unstructured":"Aaronson NK, Muller M, Cohen PDA, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MAG, Velde AT, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51(11):1055\u20131068","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"5410_CR25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","volume":"11","author":"R Ara","year":"2008","unstructured":"Ara R, Brazier J (2008) Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 11(7):1131\u20131143","journal-title":"Value Health"},{"key":"5410_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-7-27","volume":"7","author":"D Rowen","year":"2009","unstructured":"Rowen D, Brazier J, Roberts J (2009) Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 7:27","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"5410_CR27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55(2):189\u2013199","journal-title":"Breast Cancer Res Treat"},{"key":"5410_CR28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.2044-8260.1995.tb01493.x","volume":"34","author":"MS Hunter","year":"1995","unstructured":"Hunter MS, Liao KLM (1995) A psychological analysis of menopausal hot flushes. Br J Clin Psychol 34:589\u2013599","journal-title":"Br J Clin Psychol"},{"issue":"5","key":"5410_CR29","first-page":"582","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582\u2013592","journal-title":"Med Care"},{"key":"5410_CR30","volume-title":"Health measurement scales: a practical guide to their development and use","author":"DL Streiner","year":"2014","unstructured":"Streiner DL, Norman GR, Cairney J (2014) Health measurement scales: a practical guide to their development and use, 5th edn. Oxford University Press, Oxford, UK","edition":"5"},{"key":"5410_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1472-6963-13-217","volume":"13","author":"C Bouwmans","year":"2013","unstructured":"Bouwmans C, De Jong K, Timman R, Zijlstra-Vlasveld M, Van der Feltz-Cornelis C, Tan Swan S, Hakkaart-van Roijen L (2013) Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Serv Res 13:217","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"5410_CR32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00019053-200220070-00002","volume":"20","author":"JB Oostenbrink","year":"2002","unstructured":"Oostenbrink JB, Koopmanschap MA, Rutten FF (2002) Standardisation of costs: the Dutch manual for costing in economic evaluations. PharmacoEconomics 20(7):443\u2013454","journal-title":"PharmacoEconomics"},{"issue":"2","key":"5410_CR33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S0266462312000062","volume":"28","author":"SS Tan","year":"2012","unstructured":"Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L (2012) Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care 28(2):152\u2013158","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"5410_CR34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","volume":"15","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM (2012) State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force\u20133. Value Health 15(6):812\u2013820","journal-title":"Value Health"},{"key":"5410_CR35","unstructured":"Netherlands Comprehensive Cancer Organisation: Dutch Cancer Figures \n                    https:\/\/www.cijfersoverkanker.nl\/"},{"key":"5410_CR36","unstructured":"Statistics Netherlands: Mortality statistics \n                    https:\/\/statline.cbs.nl\/Statweb\/"},{"issue":"10","key":"5410_CR37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/GME.0000000000000219","volume":"21","author":"SR Davis","year":"2014","unstructured":"Davis SR, Panjari M, Robinson PJ, Fradkin P, Bell RJ (2014) Menopausal symptoms in breast cancer survivors nearly 6\u00a0years after diagnosis. Menopause 21(10):1075\u20131081","journal-title":"Menopause"},{"issue":"5","key":"5410_CR38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/cer.15.38","volume":"4","author":"R Schwarzer","year":"2015","unstructured":"Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, Flatscher-Thoeni M, Schnell-Inderst P, Sroczynski G, Lackner M et al (2015) Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J Comp Eff Res 4(5):485\u2013504","journal-title":"J Comp Eff Res"},{"issue":"2","key":"5410_CR39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","volume":"93","author":"E Marseille","year":"2015","unstructured":"Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organization 93(2):118\u2013124","journal-title":"Bull World Health Organization"},{"issue":"3","key":"5410_CR40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1345\/aph.1R417","volume":"47","author":"V Garg","year":"2013","unstructured":"Garg V, Shen X, Cheng Y, Nawarskas JJ, Raisch DW (2013) Use of number needed to treat in cost-effectiveness analyses. Ann Pharmacother 47(3):380\u2013387","journal-title":"Ann Pharmacother"},{"issue":"7028","key":"5410_CR41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.312.7028.426","volume":"312","author":"G Chatellier","year":"1996","unstructured":"Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P (1996) The number needed to treat: a clinically useful nomogram in its proper context. BMJ (Clin Res ed) 312(7028):426\u2013429","journal-title":"BMJ (Clin Res ed)"},{"issue":"5","key":"5410_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1524-4733.2007.00187.x","volume":"10","author":"JA Mauskopf","year":"2007","unstructured":"Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P (2007) Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices\u2013budget impact analysis. Value Health 10(5):336\u2013347","journal-title":"Value Health"},{"issue":"1","key":"5410_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pon.3870","volume":"25","author":"RA Willems","year":"2016","unstructured":"Willems RA, Bolman CA, Mesters I, Kanera IM, Beaulen AA, Lechner L (2016) Cancer survivors in the first year after treatment: the prevalence and correlates of unmet needs in different domains. Psychooncology 25(1):51\u201357","journal-title":"Psychooncology"},{"issue":"2","key":"5410_CR44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/0284186X.2010.531050","volume":"50","author":"L Thorsen","year":"2011","unstructured":"Thorsen L, Gjerset GM, Loge JH, Kiserud CE, Skovlund E, Flotten T, Fossa SD (2011) Cancer patients\u2019 needs for rehabilitation services. Acta Oncologica (Stockholm, Sweden) 50(2):212\u2013222","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"6","key":"5410_CR45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/pon.543","volume":"10","author":"A Plass","year":"2001","unstructured":"Plass A, Koch U (2001) Participation of oncological outpatients in psychosocial support. Psychooncology 10(6):511\u2013520","journal-title":"Psychooncology"},{"issue":"12","key":"5410_CR46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","volume":"14","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12):1165\u20131174","journal-title":"Lancet Oncol"},{"issue":"6","key":"5410_CR47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10198-017-0928-0","volume":"19","author":"BFM Wijnen","year":"2018","unstructured":"Wijnen BFM, Mosweu I, Majoie M, Ridsdale L, de Kinderen RJA, Evers S, McCrone P (2018) A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy. Eur J Health Econ 19(6):861\u2013870","journal-title":"Eur J Health Econ"},{"key":"5410_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.186.1.11","volume":"186","author":"P Bower","year":"2005","unstructured":"Bower P, Gilbody S (2005) Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. Br J Psychiatry 186:11\u201317","journal-title":"Br J Psychiatry"},{"issue":"3","key":"5410_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pon.794","volume":"13","author":"JR Bloom","year":"2004","unstructured":"Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13(3):147\u2013160","journal-title":"Psychooncology"},{"issue":"8","key":"5410_CR50","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s11136-018-1866-8","volume":"27","author":"ME Schmidt","year":"2018","unstructured":"Schmidt ME, Wiskemann J, Steindorf K (2018) Quality of life, problems, and needs of disease-free breast cancer survivors 5\u00a0years after diagnosis. Qual Life Res 27(8):2077\u20132086","journal-title":"Qual Life Res"},{"issue":"5","key":"5410_CR51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","volume":"104","author":"J Howard-Anderson","year":"2012","unstructured":"Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386\u2013405","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"5410_CR52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40273-013-0056-3","volume":"31","author":"M Krol","year":"2013","unstructured":"Krol M, Brouwer W, Rutten F (2013) Productivity costs in economic evaluations: past, present, future. PharmacoEconomics 31(7):537\u2013549","journal-title":"PharmacoEconomics"},{"key":"5410_CR53","unstructured":"Guideline for conducting economic evaluations in healthcare. \n                    https:\/\/english.zorginstituutnederland.nl\/publications\/reports\/2016\/06\/16\/guideline-for-economic-evaluations-in-healthcare"},{"issue":"6","key":"5410_CR54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11136-007-9202-8","volume":"16","author":"M Lidgren","year":"2007","unstructured":"Lidgren M, Wilking N, Jonsson B, Rehnberg C (2007) Health related quality of life in different states of breast cancer. Qual Life Res 16(6):1073\u20131081","journal-title":"Qual Life Res"},{"issue":"8","key":"5410_CR55","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ejca.2010.02.035","volume":"46","author":"VP Retel","year":"2010","unstructured":"Retel VP, Joore MA, Knauer M, Linn SC, Hauptmann M, Harten WH (2010) Cost-effectiveness of the 70-gene signature versus St Gallen guidelines and Adjuvant Online for early breast cancer. Eur J Cancer 46(8):1382\u20131391","journal-title":"Eur J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05410-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T23:16:16Z","timestamp":1598310976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05410-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5410"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05410-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"15 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Myra S. Hunter declares she receives royalties from Routledge and Boom publisher. No other conflicts of interest are present and other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}